Global Cell-free DNA Testing Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

September 2026 | 121 pages | ID: GC97798C202EEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Cell-free DNA Testing Service market size was valued at US$ 11124 million in 2025 and is forecast to a readjusted size of US$ 21205 million by 2032 with a CAGR of 9.8% during review period.

Cell-free DNA (cfDNA) testing services constitute a category of precision medicine diagnostics that involve collecting bodily fluids—such as blood or urine—to extract DNA fragments found in the extracellular environment. These services employ molecular detection technologies, including next-generation sequencing (NGS), droplet digital PCR (ddPCR), standard PCR, and methylation analysis, to analyze DNA sequence variations, gene mutations, chromosomal abnormalities, and epigenetic information, subsequently providing test reports and medical data interpretation to healthcare providers, research institutions, or individual users. Key applications of cfDNA testing include non-invasive prenatal testing (NIPT; screening for chromosomal abnormalities using fetal cfDNA), cancer liquid biopsy (using circulating tumor DNA, or ctDNA, for early cancer screening, companion diagnostics, and monitoring of minimal residual disease, or MRD), transplant monitoring (detecting donor-derived cfDNA), and genetic disease screening. Compared to traditional tissue biopsies, cfDNA testing offers advantages such as minimally invasive sampling, the feasibility of repeated testing, and the ability to dynamically monitor disease progression, making it a vital technological pathway for liquid biopsy and precision medicine.

Driven by the rapid advancement of global precision medicine, early cancer screening, personalized therapy, and genetic testing technologies, the market for cfDNA testing services holds significant growth potential. Cancer liquid biopsy is a key driver of this market growth; the detection of ctDNA within the cfDNA pool allows for the identification of tumor-associated genetic alterations in blood samples, facilitating treatment selection, therapeutic efficacy assessment, and recurrence monitoring. Simultaneously, the expanding NIPT market is propelling the commercial application of cfDNA technology in prenatal screening. Looking ahead, as the costs of next-generation sequencing decrease and ultra-sensitive detection technologies (such as methylation analysis, multi-omics analysis, and single-molecule sequencing) mature—and as early cancer screening and MRD testing enter clinical practice—cfDNA testing services are expected to expand beyond traditional prenatal screening into areas such as comprehensive cancer management, genetic disease diagnosis, and general health management, maintaining a trajectory of rapid market growth.

Report Scope

This report is a detailed and comprehensive analysis for global Cell-free DNA Testing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Cell-free DNA Testing Service market size and forecasts, in consumption value ($ Million), 2021-2032

Global Cell-free DNA Testing Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032

Global Cell-free DNA Testing Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032

Global Cell-free DNA Testing Service market shares of main players, in revenue ($ Million), 2021-2026

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Cell-free DNA Testing Service
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
  • This report profiles key players in the global Cell-free DNA Testing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Natera, CareDx, BillionToOne, Inc., ARUP Laboratories, Guardant Health, GRAIL, Foundation Medicine, BGI Genomics, Berry Genomics, Burning Rock, etc.
  • This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

  • Cell-free DNA Testing Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Targeted Sequencing
  • Whole Genome Sequencing

Market segment by Target Audiences

  • LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
  • DTC (Direct-to-Consumer) Services for Consumers

Market segment by Targets for Detection

  • Cell-free Fetal DNA (Fetal cfDNA)
  • Circulating Tumor DNA (ctDNA)
  • Donor-derived cfDNA (dd-cfDNA)

Market segment by Application

  • Prenatal Testing
  • Oncology
  • Organ Transplant Monitoring
  • Others

Market segment by players, this report covers

  • Natera
  • CareDx
  • BillionToOne, Inc.
  • ARUP Laboratories
  • Guardant Health
  • GRAIL
  • Foundation Medicine
  • BGI Genomics
  • Berry Genomics
  • Burning Rock
  • ACT Genomics
  • MedGenome
  • Lucence
  • NIPT by LifeCodexx
  • Genodive Pharma
  • Riken Genesis
  • GC Genome
  • EDGC

Market segment by regions, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
  • South America (Brazil, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Chapter Outline

Chapter 1, to describe Cell-free DNA Testing Service product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Cell-free DNA Testing Service, with revenue, gross margin, and global market share of Cell-free DNA Testing Service from 2021 to 2026.

Chapter 3, the Cell-free DNA Testing Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Cell-free DNA Testing Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Cell-free DNA Testing Service.

Chapter 13, to describe Cell-free DNA Testing Service research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell-free DNA Testing Service by Type
  1.3.1 Overview: Global Cell-free DNA Testing Service Market Size by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Global Cell-free DNA Testing Service Consumption Value Market Share by Type in 2025
  1.3.3 Targeted Sequencing
  1.3.4 Whole Genome Sequencing
1.4 Classification of Cell-free DNA Testing Service by Target Audiences
  1.4.1 Overview: Global Cell-free DNA Testing Service Market Size by Target Audiences: 2021 Versus 2025 Versus 2032
  1.4.2 Global Cell-free DNA Testing Service Consumption Value Market Share by Target Audiences in 2025
  1.4.3 LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
  1.4.4 DTC (Direct-to-Consumer) Services for Consumers
1.5 Classification of Cell-free DNA Testing Service by Targets for Detection
  1.5.1 Overview: Global Cell-free DNA Testing Service Market Size by Targets for Detection: 2021 Versus 2025 Versus 2032
  1.5.2 Global Cell-free DNA Testing Service Consumption Value Market Share by Targets for Detection in 2025
  1.5.3 Cell-free Fetal DNA (Fetal cfDNA)
  1.5.4 Circulating Tumor DNA (ctDNA)
  1.5.5 Donor-derived cfDNA (dd-cfDNA)
1.6 Global Cell-free DNA Testing Service Market by Application
  1.6.1 Overview: Global Cell-free DNA Testing Service Market Size by Application: 2021 Versus 2025 Versus 2032
  1.6.2 Prenatal Testing
  1.6.3 Oncology
  1.6.4 Organ Transplant Monitoring
  1.6.5 Others
1.7 Global Cell-free DNA Testing Service Market Size & Forecast
1.8 Global Cell-free DNA Testing Service Market Size and Forecast by Region
  1.8.1 Global Cell-free DNA Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  1.8.2 Global Cell-free DNA Testing Service Market Size by Region, (2021-2032)
  1.8.3 North America Cell-free DNA Testing Service Market Size and Prospect (2021-2032)
  1.8.4 Europe Cell-free DNA Testing Service Market Size and Prospect (2021-2032)
  1.8.5 Asia-Pacific Cell-free DNA Testing Service Market Size and Prospect (2021-2032)
  1.8.6 South America Cell-free DNA Testing Service Market Size and Prospect (2021-2032)
  1.8.7 Middle East & Africa Cell-free DNA Testing Service Market Size and Prospect (2021-2032)

2 COMPANY PROFILES
2.1 Natera
  2.1.1 Natera Details
  2.1.2 Natera Major Business
  2.1.3 Natera Cell-free DNA Testing Service Product and Solutions
  2.1.4 Natera Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Natera Recent Developments and Future Plans
2.2 CareDx
  2.2.1 CareDx Details
  2.2.2 CareDx Major Business
  2.2.3 CareDx Cell-free DNA Testing Service Product and Solutions
  2.2.4 CareDx Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 CareDx Recent Developments and Future Plans
2.3 BillionToOne, Inc.
  2.3.1 BillionToOne, Inc. Details
  2.3.2 BillionToOne, Inc. Major Business
  2.3.3 BillionToOne, Inc. Cell-free DNA Testing Service Product and Solutions
  2.3.4 BillionToOne, Inc. Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 BillionToOne, Inc. Recent Developments and Future Plans
2.4 ARUP Laboratories
  2.4.1 ARUP Laboratories Details
  2.4.2 ARUP Laboratories Major Business
  2.4.3 ARUP Laboratories Cell-free DNA Testing Service Product and Solutions
  2.4.4 ARUP Laboratories Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 ARUP Laboratories Recent Developments and Future Plans
2.5 Guardant Health
  2.5.1 Guardant Health Details
  2.5.2 Guardant Health Major Business
  2.5.3 Guardant Health Cell-free DNA Testing Service Product and Solutions
  2.5.4 Guardant Health Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Guardant Health Recent Developments and Future Plans
2.6 GRAIL
  2.6.1 GRAIL Details
  2.6.2 GRAIL Major Business
  2.6.3 GRAIL Cell-free DNA Testing Service Product and Solutions
  2.6.4 GRAIL Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 GRAIL Recent Developments and Future Plans
2.7 Foundation Medicine
  2.7.1 Foundation Medicine Details
  2.7.2 Foundation Medicine Major Business
  2.7.3 Foundation Medicine Cell-free DNA Testing Service Product and Solutions
  2.7.4 Foundation Medicine Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Foundation Medicine Recent Developments and Future Plans
2.8 BGI Genomics
  2.8.1 BGI Genomics Details
  2.8.2 BGI Genomics Major Business
  2.8.3 BGI Genomics Cell-free DNA Testing Service Product and Solutions
  2.8.4 BGI Genomics Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 BGI Genomics Recent Developments and Future Plans
2.9 Berry Genomics
  2.9.1 Berry Genomics Details
  2.9.2 Berry Genomics Major Business
  2.9.3 Berry Genomics Cell-free DNA Testing Service Product and Solutions
  2.9.4 Berry Genomics Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Berry Genomics Recent Developments and Future Plans
2.10 Burning Rock
  2.10.1 Burning Rock Details
  2.10.2 Burning Rock Major Business
  2.10.3 Burning Rock Cell-free DNA Testing Service Product and Solutions
  2.10.4 Burning Rock Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 Burning Rock Recent Developments and Future Plans
2.11 ACT Genomics
  2.11.1 ACT Genomics Details
  2.11.2 ACT Genomics Major Business
  2.11.3 ACT Genomics Cell-free DNA Testing Service Product and Solutions
  2.11.4 ACT Genomics Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 ACT Genomics Recent Developments and Future Plans
2.12 MedGenome
  2.12.1 MedGenome Details
  2.12.2 MedGenome Major Business
  2.12.3 MedGenome Cell-free DNA Testing Service Product and Solutions
  2.12.4 MedGenome Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 MedGenome Recent Developments and Future Plans
2.13 Lucence
  2.13.1 Lucence Details
  2.13.2 Lucence Major Business
  2.13.3 Lucence Cell-free DNA Testing Service Product and Solutions
  2.13.4 Lucence Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 Lucence Recent Developments and Future Plans
2.14 NIPT by LifeCodexx
  2.14.1 NIPT by LifeCodexx Details
  2.14.2 NIPT by LifeCodexx Major Business
  2.14.3 NIPT by LifeCodexx Cell-free DNA Testing Service Product and Solutions
  2.14.4 NIPT by LifeCodexx Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.14.5 NIPT by LifeCodexx Recent Developments and Future Plans
2.15 Genodive Pharma
  2.15.1 Genodive Pharma Details
  2.15.2 Genodive Pharma Major Business
  2.15.3 Genodive Pharma Cell-free DNA Testing Service Product and Solutions
  2.15.4 Genodive Pharma Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.15.5 Genodive Pharma Recent Developments and Future Plans
2.16 Riken Genesis
  2.16.1 Riken Genesis Details
  2.16.2 Riken Genesis Major Business
  2.16.3 Riken Genesis Cell-free DNA Testing Service Product and Solutions
  2.16.4 Riken Genesis Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.16.5 Riken Genesis Recent Developments and Future Plans
2.17 GC Genome
  2.17.1 GC Genome Details
  2.17.2 GC Genome Major Business
  2.17.3 GC Genome Cell-free DNA Testing Service Product and Solutions
  2.17.4 GC Genome Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.17.5 GC Genome Recent Developments and Future Plans
2.18 EDGC
  2.18.1 EDGC Details
  2.18.2 EDGC Major Business
  2.18.3 EDGC Cell-free DNA Testing Service Product and Solutions
  2.18.4 EDGC Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.18.5 EDGC Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell-free DNA Testing Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
  3.2.1 Market Share of Cell-free DNA Testing Service by Company Revenue
  3.2.2 Top 3 Cell-free DNA Testing Service Players Market Share in 2025
  3.2.3 Top 6 Cell-free DNA Testing Service Players Market Share in 2025
3.3 Cell-free DNA Testing Service Market: Overall Company Footprint Analysis
  3.3.1 Cell-free DNA Testing Service Market: Region Footprint
  3.3.2 Cell-free DNA Testing Service Market: Company Product Type Footprint
  3.3.3 Cell-free DNA Testing Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell-free DNA Testing Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global Cell-free DNA Testing Service Market Forecast by Type (2027-2032)

5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell-free DNA Testing Service Consumption Value Market Share by Application (2021-2026)
5.2 Global Cell-free DNA Testing Service Market Forecast by Application (2027-2032)

6 NORTH AMERICA
6.1 North America Cell-free DNA Testing Service Consumption Value by Type (2021-2032)
6.2 North America Cell-free DNA Testing Service Market Size by Application (2021-2032)
6.3 North America Cell-free DNA Testing Service Market Size by Country
  6.3.1 North America Cell-free DNA Testing Service Consumption Value by Country (2021-2032)
  6.3.2 United States Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  6.3.3 Canada Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  6.3.4 Mexico Cell-free DNA Testing Service Market Size and Forecast (2021-2032)

7 EUROPE
7.1 Europe Cell-free DNA Testing Service Consumption Value by Type (2021-2032)
7.2 Europe Cell-free DNA Testing Service Consumption Value by Application (2021-2032)
7.3 Europe Cell-free DNA Testing Service Market Size by Country
  7.3.1 Europe Cell-free DNA Testing Service Consumption Value by Country (2021-2032)
  7.3.2 Germany Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  7.3.3 France Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  7.3.4 United Kingdom Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  7.3.5 Russia Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  7.3.6 Italy Cell-free DNA Testing Service Market Size and Forecast (2021-2032)

8 ASIA-PACIFIC
8.1 Asia-Pacific Cell-free DNA Testing Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Cell-free DNA Testing Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Cell-free DNA Testing Service Market Size by Region
  8.3.1 Asia-Pacific Cell-free DNA Testing Service Consumption Value by Region (2021-2032)
  8.3.2 China Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  8.3.3 Japan Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  8.3.4 South Korea Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  8.3.5 India Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  8.3.6 Southeast Asia Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  8.3.7 Australia Cell-free DNA Testing Service Market Size and Forecast (2021-2032)

9 SOUTH AMERICA
9.1 South America Cell-free DNA Testing Service Consumption Value by Type (2021-2032)
9.2 South America Cell-free DNA Testing Service Consumption Value by Application (2021-2032)
9.3 South America Cell-free DNA Testing Service Market Size by Country
  9.3.1 South America Cell-free DNA Testing Service Consumption Value by Country (2021-2032)
  9.3.2 Brazil Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  9.3.3 Argentina Cell-free DNA Testing Service Market Size and Forecast (2021-2032)

10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell-free DNA Testing Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Cell-free DNA Testing Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Cell-free DNA Testing Service Market Size by Country
  10.3.1 Middle East & Africa Cell-free DNA Testing Service Consumption Value by Country (2021-2032)
  10.3.2 Turkey Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  10.3.3 Saudi Arabia Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
  10.3.4 UAE Cell-free DNA Testing Service Market Size and Forecast (2021-2032)

11 MARKET DYNAMICS
11.1 Cell-free DNA Testing Service Market Drivers
11.2 Cell-free DNA Testing Service Market Restraints
11.3 Cell-free DNA Testing Service Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS
12.1 Cell-free DNA Testing Service Industry Chain
12.2 Cell-free DNA Testing Service Upstream Analysis
12.3 Cell-free DNA Testing Service Midstream Analysis
12.4 Cell-free DNA Testing Service Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES

Table 1. Global Cell-free DNA Testing Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Cell-free DNA Testing Service Consumption Value by Target Audiences, (USD Million), 2021 & 2025 & 2032
Table 3. Global Cell-free DNA Testing Service Consumption Value by Targets for Detection, (USD Million), 2021 & 2025 & 2032
Table 4. Global Cell-free DNA Testing Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Cell-free DNA Testing Service Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Cell-free DNA Testing Service Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Natera Company Information, Head Office, and Major Competitors
Table 8. Natera Major Business
Table 9. Natera Cell-free DNA Testing Service Product and Solutions
Table 10. Natera Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Natera Recent Developments and Future Plans
Table 12. CareDx Company Information, Head Office, and Major Competitors
Table 13. CareDx Major Business
Table 14. CareDx Cell-free DNA Testing Service Product and Solutions
Table 15. CareDx Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. CareDx Recent Developments and Future Plans
Table 17. BillionToOne, Inc. Company Information, Head Office, and Major Competitors
Table 18. BillionToOne, Inc. Major Business
Table 19. BillionToOne, Inc. Cell-free DNA Testing Service Product and Solutions
Table 20. BillionToOne, Inc. Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. ARUP Laboratories Company Information, Head Office, and Major Competitors
Table 22. ARUP Laboratories Major Business
Table 23. ARUP Laboratories Cell-free DNA Testing Service Product and Solutions
Table 24. ARUP Laboratories Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. ARUP Laboratories Recent Developments and Future Plans
Table 26. Guardant Health Company Information, Head Office, and Major Competitors
Table 27. Guardant Health Major Business
Table 28. Guardant Health Cell-free DNA Testing Service Product and Solutions
Table 29. Guardant Health Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Guardant Health Recent Developments and Future Plans
Table 31. GRAIL Company Information, Head Office, and Major Competitors
Table 32. GRAIL Major Business
Table 33. GRAIL Cell-free DNA Testing Service Product and Solutions
Table 34. GRAIL Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. GRAIL Recent Developments and Future Plans
Table 36. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 37. Foundation Medicine Major Business
Table 38. Foundation Medicine Cell-free DNA Testing Service Product and Solutions
Table 39. Foundation Medicine Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Foundation Medicine Recent Developments and Future Plans
Table 41. BGI Genomics Company Information, Head Office, and Major Competitors
Table 42. BGI Genomics Major Business
Table 43. BGI Genomics Cell-free DNA Testing Service Product and Solutions
Table 44. BGI Genomics Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. BGI Genomics Recent Developments and Future Plans
Table 46. Berry Genomics Company Information, Head Office, and Major Competitors
Table 47. Berry Genomics Major Business
Table 48. Berry Genomics Cell-free DNA Testing Service Product and Solutions
Table 49. Berry Genomics Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Berry Genomics Recent Developments and Future Plans
Table 51. Burning Rock Company Information, Head Office, and Major Competitors
Table 52. Burning Rock Major Business
Table 53. Burning Rock Cell-free DNA Testing Service Product and Solutions
Table 54. Burning Rock Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Burning Rock Recent Developments and Future Plans
Table 56. ACT Genomics Company Information, Head Office, and Major Competitors
Table 57. ACT Genomics Major Business
Table 58. ACT Genomics Cell-free DNA Testing Service Product and Solutions
Table 59. ACT Genomics Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. ACT Genomics Recent Developments and Future Plans
Table 61. MedGenome Company Information, Head Office, and Major Competitors
Table 62. MedGenome Major Business
Table 63. MedGenome Cell-free DNA Testing Service Product and Solutions
Table 64. MedGenome Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. MedGenome Recent Developments and Future Plans
Table 66. Lucence Company Information, Head Office, and Major Competitors
Table 67. Lucence Major Business
Table 68. Lucence Cell-free DNA Testing Service Product and Solutions
Table 69. Lucence Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Lucence Recent Developments and Future Plans
Table 71. NIPT by LifeCodexx Company Information, Head Office, and Major Competitors
Table 72. NIPT by LifeCodexx Major Business
Table 73. NIPT by LifeCodexx Cell-free DNA Testing Service Product and Solutions
Table 74. NIPT by LifeCodexx Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. NIPT by LifeCodexx Recent Developments and Future Plans
Table 76. Genodive Pharma Company Information, Head Office, and Major Competitors
Table 77. Genodive Pharma Major Business
Table 78. Genodive Pharma Cell-free DNA Testing Service Product and Solutions
Table 79. Genodive Pharma Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Genodive Pharma Recent Developments and Future Plans
Table 81. Riken Genesis Company Information, Head Office, and Major Competitors
Table 82. Riken Genesis Major Business
Table 83. Riken Genesis Cell-free DNA Testing Service Product and Solutions
Table 84. Riken Genesis Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Riken Genesis Recent Developments and Future Plans
Table 86. GC Genome Company Information, Head Office, and Major Competitors
Table 87. GC Genome Major Business
Table 88. GC Genome Cell-free DNA Testing Service Product and Solutions
Table 89. GC Genome Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. GC Genome Recent Developments and Future Plans
Table 91. EDGC Company Information, Head Office, and Major Competitors
Table 92. EDGC Major Business
Table 93. EDGC Cell-free DNA Testing Service Product and Solutions
Table 94. EDGC Cell-free DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. EDGC Recent Developments and Future Plans
Table 96. Global Cell-free DNA Testing Service Revenue (USD Million) by Players (2021-2026)
Table 97. Global Cell-free DNA Testing Service Revenue Share by Players (2021-2026)
Table 98. Breakdown of Cell-free DNA Testing Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 99. Market Position of Players in Cell-free DNA Testing Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 100. Head Office of Key Cell-free DNA Testing Service Players
Table 101. Cell-free DNA Testing Service Market: Company Product Type Footprint
Table 102. Cell-free DNA Testing Service Market: Company Product Application Footprint
Table 103. Cell-free DNA Testing Service New Market Entrants and Barriers to Market Entry
Table 104. Cell-free DNA Testing Service Mergers, Acquisition, Agreements, and Collaborations
Table 105. Global Cell-free DNA Testing Service Consumption Value (USD Million) by Type (2021-2026)
Table 106. Global Cell-free DNA Testing Service Consumption Value Share by Type (2021-2026)
Table 107. Global Cell-free DNA Testing Service Consumption Value Forecast by Type (2027-2032)
Table 108. Global Cell-free DNA Testing Service Consumption Value by Application (2021-2026)
Table 109. Global Cell-free DNA Testing Service Consumption Value Forecast by Application (2027-2032)
Table 110. North America Cell-free DNA Testing Service Consumption Value by Type (2021-2026) & (USD Million)
Table 111. North America Cell-free DNA Testing Service Consumption Value by Type (2027-2032) & (USD Million)
Table 112. North America Cell-free DNA Testing Service Consumption Value by Application (2021-2026) & (USD Million)
Table 113. North America Cell-free DNA Testing Service Consumption Value by Application (2027-2032) & (USD Million)
Table 114. North America Cell-free DNA Testing Service Consumption Value by Country (2021-2026) & (USD Million)
Table 115. North America Cell-free DNA Testing Service Consumption Value by Country (2027-2032) & (USD Million)
Table 116. Europe Cell-free DNA Testing Service Consumption Value by Type (2021-2026) & (USD Million)
Table 117. Europe Cell-free DNA Testing Service Consumption Value by Type (2027-2032) & (USD Million)
Table 118. Europe Cell-free DNA Testing Service Consumption Value by Application (2021-2026) & (USD Million)
Table 119. Europe Cell-free DNA Testing Service Consumption Value by Application (2027-2032) & (USD Million)
Table 120. Europe Cell-free DNA Testing Service Consumption Value by Country (2021-2026) & (USD Million)
Table 121. Europe Cell-free DNA Testing Service Consumption Value by Country (2027-2032) & (USD Million)
Table 122. Asia-Pacific Cell-free DNA Testing Service Consumption Value by Type (2021-2026) & (USD Million)
Table 123. Asia-Pacific Cell-free DNA Testing Service Consumption Value by Type (2027-2032) & (USD Million)
Table 124. Asia-Pacific Cell-free DNA Testing Service Consumption Value by Application (2021-2026) & (USD Million)
Table 125. Asia-Pacific Cell-free DNA Testing Service Consumption Value by Application (2027-2032) & (USD Million)
Table 126. Asia-Pacific Cell-free DNA Testing Service Consumption Value by Region (2021-2026) & (USD Million)
Table 127. Asia-Pacific Cell-free DNA Testing Service Consumption Value by Region (2027-2032) & (USD Million)
Table 128. South America Cell-free DNA Testing Service Consumption Value by Type (2021-2026) & (USD Million)
Table 129. South America Cell-free DNA Testing Service Consumption Value by Type (2027-2032) & (USD Million)
Table 130. South America Cell-free DNA Testing Service Consumption Value by Application (2021-2026) & (USD Million)
Table 131. South America Cell-free DNA Testing Service Consumption Value by Application (2027-2032) & (USD Million)
Table 132. South America Cell-free DNA Testing Service Consumption Value by Country (2021-2026) & (USD Million)
Table 133. South America Cell-free DNA Testing Service Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Middle East & Africa Cell-free DNA Testing Service Consumption Value by Type (2021-2026) & (USD Million)
Table 135. Middle East & Africa Cell-free DNA Testing Service Consumption Value by Type (2027-2032) & (USD Million)
Table 136. Middle East & Africa Cell-free DNA Testing Service Consumption Value by Application (2021-2026) & (USD Million)
Table 137. Middle East & Africa Cell-free DNA Testing Service Consumption Value by Application (2027-2032) & (USD Million)
Table 138. Middle East & Africa Cell-free DNA Testing Service Consumption Value by Country (2021-2026) & (USD Million)
Table 139. Middle East & Africa Cell-free DNA Testing Service Consumption Value by Country (2027-2032) & (USD Million)
Table 140. Global Key Players of Cell-free DNA Testing Service Upstream (Raw Materials)
Table 141. Global Cell-free DNA Testing Service Typical Customers

LIST OF FIGURES

Figure 1. Cell-free DNA Testing Service Picture
Figure 2. Global Cell-free DNA Testing Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Cell-free DNA Testing Service Consumption Value Market Share by Type in 2025
Figure 4. Targeted Sequencing
Figure 5. Whole Genome Sequencing
Figure 6. Global Cell-free DNA Testing Service Consumption Value by Target Audiences, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Cell-free DNA Testing Service Consumption Value Market Share by Target Audiences in 2025
Figure 8. LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
Figure 9. DTC (Direct-to-Consumer) Services for Consumers
Figure 10. Global Cell-free DNA Testing Service Consumption Value by Targets for Detection, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Cell-free DNA Testing Service Consumption Value Market Share by Targets for Detection in 2025
Figure 12. Cell-free Fetal DNA (Fetal cfDNA)
Figure 13. Circulating Tumor DNA (ctDNA)
Figure 14. Donor-derived cfDNA (dd-cfDNA)
Figure 15. Global Cell-free DNA Testing Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Cell-free DNA Testing Service Consumption Value Market Share by Application in 2025
Figure 17. Prenatal Testing Picture
Figure 18. Oncology Picture
Figure 19. Organ Transplant Monitoring Picture
Figure 20. Others Picture
Figure 21. Global Cell-free DNA Testing Service Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Cell-free DNA Testing Service Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Market Cell-free DNA Testing Service Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 24. Global Cell-free DNA Testing Service Consumption Value Market Share by Region (2021-2032)
Figure 25. Global Cell-free DNA Testing Service Consumption Value Market Share by Region in 2025
Figure 26. North America Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 27. Europe Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 28. Asia-Pacific Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 29. South America Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 30. Middle East & Africa Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 31. Company Three Recent Developments and Future Plans
Figure 32. Global Cell-free DNA Testing Service Revenue Share by Players in 2025
Figure 33. Cell-free DNA Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 34. Market Share of Cell-free DNA Testing Service by Player Revenue in 2025
Figure 35. Top 3 Cell-free DNA Testing Service Players Market Share in 2025
Figure 36. Top 6 Cell-free DNA Testing Service Players Market Share in 2025
Figure 37. Global Cell-free DNA Testing Service Consumption Value Share by Type (2021-2026)
Figure 38. Global Cell-free DNA Testing Service Market Share Forecast by Type (2027-2032)
Figure 39. Global Cell-free DNA Testing Service Consumption Value Share by Application (2021-2026)
Figure 40. Global Cell-free DNA Testing Service Market Share Forecast by Application (2027-2032)
Figure 41. North America Cell-free DNA Testing Service Consumption Value Market Share by Type (2021-2032)
Figure 42. North America Cell-free DNA Testing Service Consumption Value Market Share by Application (2021-2032)
Figure 43. North America Cell-free DNA Testing Service Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Cell-free DNA Testing Service Consumption Value Market Share by Type (2021-2032)
Figure 48. Europe Cell-free DNA Testing Service Consumption Value Market Share by Application (2021-2032)
Figure 49. Europe Cell-free DNA Testing Service Consumption Value Market Share by Country (2021-2032)
Figure 50. Germany Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 51. France Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 52. United Kingdom Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 53. Russia Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 54. Italy Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific Cell-free DNA Testing Service Consumption Value Market Share by Type (2021-2032)
Figure 56. Asia-Pacific Cell-free DNA Testing Service Consumption Value Market Share by Application (2021-2032)
Figure 57. Asia-Pacific Cell-free DNA Testing Service Consumption Value Market Share by Region (2021-2032)
Figure 58. China Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 61. India Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Cell-free DNA Testing Service Consumption Value Market Share by Type (2021-2032)
Figure 65. South America Cell-free DNA Testing Service Consumption Value Market Share by Application (2021-2032)
Figure 66. South America Cell-free DNA Testing Service Consumption Value Market Share by Country (2021-2032)
Figure 67. Brazil Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 68. Argentina Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 69. Middle East & Africa Cell-free DNA Testing Service Consumption Value Market Share by Type (2021-2032)
Figure 70. Middle East & Africa Cell-free DNA Testing Service Consumption Value Market Share by Application (2021-2032)
Figure 71. Middle East & Africa Cell-free DNA Testing Service Consumption Value Market Share by Country (2021-2032)
Figure 72. Turkey Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 74. UAE Cell-free DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 75. Cell-free DNA Testing Service Market Drivers
Figure 76. Cell-free DNA Testing Service Market Restraints
Figure 77. Cell-free DNA Testing Service Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Cell-free DNA Testing Service Industrial Chain
Figure 80. Methodology
Figure 81. Research Process and Data Source